Cargando…

SARS-CoV-2 and diabetes: A potential therapeutic effect of dipeptidyl peptidase 4 inhibitors in diabetic patients diagnosed with COVID-19

COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 and has become an urgent economic and health challenge. Dipeptidyl peptidase 4 (DPP4), also mentioned as a cluster of differentiation 26 (CD26) is a serine exopeptidase found in two arrangements: a soluble form (sDPP-4) and a plas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kifle, Zemene Demelash, Woldeyohanin, Alem Endeshaw, Demeke, Chilot Abiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	COVID-19 in Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511553/ https://www.ncbi.nlm.nih.gov/pubmed/34661092 http://dx.doi.org/10.1016/j.metop.2021.100134

Ejemplares similares

A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Herbal medicine use for the management of COVID-19: A review article
por: Demeke, Chilot Abiyu, et al.
Publicado: (2021)

In vivo hypoglycemic, antihyperglycemic and antidyslipidemic effects of the solvent fractions of Hagenia abyssinica leaves in mice
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Availability and Utilization of World Health Organization Recommended Priority Life-Saving Medicines for Under Five-Year-Old Children in Gondar Town, Ethiopia: A Cross-Sectional Study
por: Woldeyohanins, Alem Endeshaw, et al.
Publicado: (2021)

Availability and Utilization of the WHO-Recommended Lifesaving Medicines for Under-Five Children at University of Gondar Comprehensive Specialized Hospital, Amhara Region, Ethiopia
por: Woldeyohanins, Alem Endeshaw, et al.
Publicado: (2021)

Compliance of Private Pharmacy Retail Outlets to Narcotic Drug Regulations in Ethiopia: A Cross-Sectional and Simulated Client Study Method
por: Kasahun, Asmamaw Emagn, et al.
Publicado: (2022)

Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review
por: Kifle, Zemene Demelash
Publicado: (2021)

COVID-19 vaccine hesitancy among health professionals in a tertiary care center at the University of Gondar Specialized Hospital, Ethiopia: A cross-sectional study
por: Demeke, Chilot Abiyu, et al.
Publicado: (2022)

Impact of COVID-19 on Pharmaceutical Care Services and the Role of Community Pharmacists: A Multi-Center Cross-Sectional Study in Ethiopia
por: Yimenu, Dawit Kumilachew, et al.
Publicado: (2021)

Prevalence and associated factors of herbal medicine use among adult diabetes mellitus patients at government hospital, Ethiopia: An institutional-based cross-sectional study
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

The proportion of chronic kidney disease and its associated factors among adult diabetic patients at Tibebe Ghion Specialized Hospital, Bahir Dar, Ethiopia
por: Tesfe, Daniel, et al.
Publicado: (2022)

Dipeptidyl peptidase 3 modulates the renin–angiotensin system in mice
por: Jha, Shalinee, et al.
Publicado: (2020)

Post COVID-19 Vaccination Side Effects and Associated Factors Among Vaccinated Clients in Bahir Dar City, Ethiopia
por: Siraj, Ebrahim Abdela, et al.
Publicado: (2023)

Diabetic ketoacidosis in pediatric patients with type 1- and type 2 diabetes during the COVID-19 pandemic()
por: Loh, Charlotte, et al.
Publicado: (2021)

A Case of Euglycemic Diabetic Ketoacidosis (DKA), Influenza, and a Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
por: Jeong, Su Hyun, et al.
Publicado: (2023)

Knowledge, Attitude, and Practices of Unused Medications Disposal among Patients Visiting Public Health Centers in Gondar Town, Ethiopia: A Cross-Sectional Study
por: Woldeyohanins, Alem Endeshaw, et al.
Publicado: (2021)

Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19
por: Calvisi, Stefania L., et al.
Publicado: (2021)

Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: Population-based, prospective cohort study
por: Hamer, Mark, et al.
Publicado: (2020)

Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity()()
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

The Role of Dipeptidyl Peptidase – 4 Inhibitors in Diabetic Kidney Disease
por: Panchapakesan, Usha, et al.
Publicado: (2015)

Availability of Essential Antidotes and the Role of Community Pharmacists in the Management of Acute Poisoning: A Cross-Sectional Study in Ethiopia
por: Kifle, Zemene Demelash, et al.
Publicado: (2022)

New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
por: Cui, Chenkai, et al.
Publicado: (2022)

Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19
por: Dalamaga, Maria, et al.
Publicado: (2020)

COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic
por: Tessier, Christopher M., et al.
Publicado: (2021)

Prevalence and correlates of complementary and alternative medicine use among diabetic patients in a resource-limited setting
por: Kifle, Zemene Demelash
Publicado: (2021)

Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
por: Jang, Yun-Mi, et al.
Publicado: (2011)

Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals
por: Davis, Joseph A., et al.
Publicado: (2010)

Dipeptidyl peptidase-4 and kidney fibrosis in diabetes
por: Shi, Sen, et al.
Publicado: (2016)

Assessment of lifestyle changes during coronavirus disease 2019 pandemic in Gondar town, Northwest Ethiopia
por: Kifle, Zemene Demelash, et al.
Publicado: (2022)

Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Therapy in the Management of Latent Autoimmune Diabetes in Adults (LADA): A Systematic Review and Meta Analysis
por: Alanes Escueta, Luz Margaret, et al.
Publicado: (2021)

Virological failure and associated factors among children receiving anti-retroviral therapy, Northwest Ethiopia
por: Bayleyegn, Biruk, et al.
Publicado: (2021)

The Association of Cardiovascular Diseases and Diabetes Mellitus with COVID-19 (SARS-CoV-2) and Their Possible Mechanisms
por: Roy, Sourav, et al.
Publicado: (2020)

Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes
por: Richter, Bernd, et al.
Publicado: (2008)

Linagliptin—A Novel Dipeptidyl Peptidase Inhibitor for Type 2 Diabetes Therapy
por: Gallwitz, Baptist
Publicado: (2012)

Dipeptidyl peptidase‐4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?
por: Yabe, Daisuke, et al.
Publicado: (2014)

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy – focus on alogliptin
por: Capuano, Annalisa, et al.
Publicado: (2013)

Role of dipeptidyl peptidase-4 inhibitors in new-onset diabetes after transplantation
por: Lim, Sun Woo, et al.
Publicado: (2015)

Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes infected with coronavirus-19
por: Chen, Chun-Fan, et al.
Publicado: (2020)

Dipeptidyl Peptidase-4 Inhibitors and Diabetic Kidney Disease: A Narrative Review
por: Daza-Arnedo, Rodrigo, et al.
Publicado: (2021)

Roles of existing drug and drug targets for COVID-19 management
por: Ayele, Akeberegn Gorems, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_saf56h8tj52791vtcqf8jtku5o